225 related articles for article (PubMed ID: 32178737)
1. Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury.
Lin CF; Hsu KC; HuangFu WC; Lin TE; Huang HL; Pan SL
BMC Pharmacol Toxicol; 2020 Mar; 21(1):21. PubMed ID: 32178737
[TBL] [Abstract][Full Text] [Related]
2. Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease.
Lorenzo Pisarello M; Masyuk TV; Gradilone SA; Masyuk AI; Ding JF; Lee PY; LaRusso NF
Am J Pathol; 2018 Apr; 188(4):981-994. PubMed ID: 29366679
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.
Aune SE; Herr DJ; Mani SK; Menick DR
J Mol Cell Cardiol; 2014 Jul; 72():138-45. PubMed ID: 24632412
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy.
Xie M; Kong Y; Tan W; May H; Battiprolu PK; Pedrozo Z; Wang ZV; Morales C; Luo X; Cho G; Jiang N; Jessen ME; Warner JJ; Lavandero S; Gillette TG; Turer AT; Hill JA
Circulation; 2014 Mar; 129(10):1139-51. PubMed ID: 24396039
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase 6 inhibitor ACY1215 offers a protective effect through the autophagy pathway in acute liver failure.
Chen Q; Wang Y; Jiao FZ; Shi CX; Gong ZJ
Life Sci; 2019 Dec; 238():116976. PubMed ID: 31634464
[TBL] [Abstract][Full Text] [Related]
6. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
7. HDAC6 inhibitor ACY1215 inhibits the activation of NLRP3 inflammasome in acute liver failure by regulating the ATM/F-actin signalling pathway.
Chen Q; Wang Y; Jiao F; Cao P; Shi C; Pei M; Wang L; Gong Z
J Cell Mol Med; 2021 Aug; 25(15):7218-7228. PubMed ID: 34180140
[TBL] [Abstract][Full Text] [Related]
8. HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics.
Laino AS; Betts BC; Veerapathran A; Dolgalev I; Sarnaik A; Quayle SN; Jones SS; Weber JS; Woods DM
J Immunother Cancer; 2019 Feb; 7(1):33. PubMed ID: 30728070
[TBL] [Abstract][Full Text] [Related]
9. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.
Neckář J; Hsu A; Hye Khan MA; Gross GJ; Nithipatikom K; Cyprová M; Benák D; Hlaváčková M; Sotáková-Kašparová D; Falck JR; Sedmera D; Kolář F; Imig JD
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1148-H1158. PubMed ID: 30074840
[TBL] [Abstract][Full Text] [Related]
10. HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice.
Sakloth F; Manouras L; Avrampou K; Mitsi V; Serafini RA; Pryce KD; Cogliani V; Berton O; Jarpe M; Zachariou V
Psychopharmacology (Berl); 2020 Jul; 237(7):2139-2149. PubMed ID: 32388618
[TBL] [Abstract][Full Text] [Related]
11. HDAC6 inhibitor ACY-1215 improves neuropathic pain and its comorbidities in rats of peripheral nerve injury by regulating neuroinflammation.
Chen C; Liu A; Lu Q; Luo L; Li J; Ke J; Liu Y; Feng X
Chem Biol Interact; 2022 Feb; 353():109803. PubMed ID: 34998817
[TBL] [Abstract][Full Text] [Related]
12. Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning.
Kalakech H; Tamareille S; Pons S; Godin-Ribuot D; Carmeliet P; Furber A; Martin V; Berdeaux A; Ghaleh B; Prunier F
J Mol Cell Cardiol; 2013 Dec; 65():98-104. PubMed ID: 24140799
[TBL] [Abstract][Full Text] [Related]
13. ACY‑1215, a HDAC6 inhibitor, decreases the dexamethasone‑induced suppression of osteogenesis in MC3T3‑E1 cells.
Wang N; Wang H; Chen J; Wang F; Wang S; Zhou Q; Ying J; Huang S; Wang P; Yuan F
Mol Med Rep; 2020 Sep; 22(3):2451-2459. PubMed ID: 32705192
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 6 inhibitor ACY1215 ameliorates mitochondrial dynamic and function injury in hepatocytes by activating AMPK signaling pathway in acute liver failure mice.
Chen Q; Wang Y; Jiao F; Shi C; Pei M; Wang L; Gong Z
Histol Histopathol; 2020 Sep; 35(9):1047-1058. PubMed ID: 32572875
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy.
Chen X; Yu C; Hou X; Li J; Li T; Qiu A; Liu N; Zhuang S
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1003-F1014. PubMed ID: 33103445
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1alpha.
Zhao HX; Wang XL; Wang YH; Wu Y; Li XY; Lv XP; Zhao ZQ; Zhao RR; Liu HR
Basic Res Cardiol; 2010 Jan; 105(1):109-18. PubMed ID: 19597757
[TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor, Vorinostat, represses hypoxia inducible factor 1 alpha expression through translational inhibition.
Hutt DM; Roth DM; Vignaud H; Cullin C; Bouchecareilh M
PLoS One; 2014; 9(8):e106224. PubMed ID: 25166596
[TBL] [Abstract][Full Text] [Related]
18. Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury.
Yuan H; Li H; Yu P; Fan Q; Zhang X; Huang W; Shen J; Cui Y; Zhou W
BMC Ophthalmol; 2018 Nov; 18(1):300. PubMed ID: 30453928
[TBL] [Abstract][Full Text] [Related]
19. Isoform 6-selective histone deacetylase inhibition reduces lesion size and brain swelling following traumatic brain injury and hemorrhagic shock.
Nikolian VC; Dennahy IS; Weykamp M; Williams AM; Bhatti UF; Eidy H; Ghandour MH; Chtraklin K; Li Y; Alam HB
J Trauma Acute Care Surg; 2019 Feb; 86(2):232-239. PubMed ID: 30399139
[TBL] [Abstract][Full Text] [Related]
20. LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1α Expression.
Yao ZG; Li WH; Hua F; Cheng HX; Zhao MQ; Sun XC; Qin YJ; Li JM
J Neuropathol Exp Neurol; 2017 Dec; 76(12):1000-1007. PubMed ID: 29136455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
